IL-33 can recruit MDSCs and TAMs to support tumor growth but can also stimulate the infiltration of cytotoxic NK cells and CD8+T cells to regress tumor growth (Fournie & Poupot, 2018). The gene discussed is CD8A; the disease is neoplasm.